Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M. I. Vos, Michael Storek, Nancy Wong, Parija Patel, Xiaoyu Jiang, Deepthi S. Vagge, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M. Broome

Blood (2022) 140 (9): 980–991.

https://doi.org/10.1182/blood.2021014955

Published: 2022

Includes: Supplemental data

Journal Articles

Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study

Blood (2021) 138 (Supplement 1): 349.

https://doi.org/10.1182/blood-2021-148066

Published: 2021

Journal Articles

Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice

Javier Raboso-Gallego, Ana Casado-García, Xiaoyu Jiang, Marta Isidro-Hernández, Andrew J. Gentles, Shuchun Zhao, Yaso Natkunam, Oscar Blanco, Verónica Domínguez, Belén Pintado, Diego Alonso-López, Javier De Las Rivas, Carolina Vicente-Dueñas, Izidore S. Lossos, Isidro Sanchez-Garcia

Blood (2021) 137 (13): 1741–1753.

https://doi.org/10.1182/blood.2020004996

Published: 2021

Includes: Supplemental data

Journal Articles

Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Catherine M. Broome, Alexander Röth, MD, David J. Kuter, MD, Marie Scully, MD, Roy Smith, Jennifer Wang, Xiaoyu Jiang, Caroline Reuter, Ahmed Daak, William Hobbs

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-139663

Published: 2020

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Alexander Röth, MD, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, MD, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C. Weitz, Parija Patel, Xiaoyu Jiang, Caroline Reuter, Jun Su, Frank Shafer, Michelle Lee, William Hobbs, Sigbjørn Berentsen

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138909

Published: 2020

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma

Blood (2016) 128 (2): 239–248.

https://doi.org/10.1182/blood-2016-02-696856

Published: 2016

Includes: Supplemental data

Journal Articles

miR-181a negatively regulates NF-κB signaling and affects activated B-cell–like diffuse large B-cell lymphoma pathogenesis

Goldi A. Kozloski, Xiaoyu Jiang, Shruti Bhatt, Jose Ruiz, Francisco Vega, Rita Shaknovich, Ari Melnick, Izidore S. Lossos

Blood (2016) 127 (23): 2856–2866.

https://doi.org/10.1182/blood-2015-11-680462

Published: 2016

Includes: Supplemental data

Journal Articles

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo

Blood (2016) 127 (22): 2723–2731.

https://doi.org/10.1182/blood-2015-07-659938

Published: 2016

Includes: Supplemental data

Journal Articles

FBXO10 Targets HGAL for Degradation

Fengjie Guo, PhD, Xiaoyu Jiang, PhD, Domenico Roberti, Lixin Rui, PhD, Izidore S Lossos, MD

Blood (2015) 126 (23): 3904.

https://doi.org/10.1182/blood.V126.23.3904.3904

Published: 2015

Journal Articles

Grb2 Directly Interacts with HGAL and Ameliorates Its Effects on B-Cell Receptor Signaling

Xiaoyu Jiang, PhD, Xiaoqing Lu, Brett J Schuchardt, David C Mikles, Amjad Farooq, Vincent Moy, PhD, Izidore S Lossos, MD

Blood (2015) 126 (23): 702.

https://doi.org/10.1182/blood.V126.23.702.702

Published: 2015

Journal Articles

Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma

Shruti Bhatt, Julie Matthews, Salma Parvin, Kristopher A. Sarosiek, Dekuang Zhao, Xiaoyu Jiang, Elif Isik, Anthony Letai, Izidore S. Lossos

Blood (2015) 126 (13): 1555–1564.

https://doi.org/10.1182/blood-2015-01-624585

Published: 2015

Includes: Supplemental data

Journal Articles

HGAL localization to cell membrane regulates B-cell receptor signaling

Xiaoqing Lu, Renaud Sicard, Xiaoyu Jiang, Jessica N. Stockus, George McNamara, Midhat Abdulreda, Vincent T. Moy, Ralf Landgraf, Izidore S. Lossos

Blood (2015) 125 (4): 649–657.

https://doi.org/10.1182/blood-2014-04-571331

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

Mirna-181a expression Lead to Longer Animal Survival and Slower Tumor-Growth Rate in Diffuse Large B-Cell Lymphoma Xenograft Models

Goldi A Kozloski, PhD, Xiaoyu Jiang, PhD, Shruti Bhatt, PhD, Rita Shaknovich, MD PhD, Ari M Melnick, MD, Izidore S Lossos, MD

Blood (2014) 124 (21): 2963.

https://doi.org/10.1182/blood.V124.21.2963.2963

Published: 2014

Journal Articles

Integrative Genomics Reveals a Role for GNA13 in Lymphomagenesis within the Germinal Center Niche

Jane Healy, MD PhD, Adrienne Greenough, PhD, Rachel Rempel, PhD, Moffitt Andrea, Izidore S Lossos, MD, Xiaoyu Jiang, PhD, Sandeep S. Dave, MD

Blood (2014) 124 (21): 782.

https://doi.org/10.1182/blood.V124.21.782.782

Published: 2014

Journal Articles

Targeting B-Cell Malignancies With Anti-CD20-Interleukin-21 Fusokine

Shruti Bhatt, MS, Daxing Zhu, MD, Xiaoyu Jiang, PhD, Seung-uon Shin, PhD, John M Timmerman, MD, Joseph D. Rosenblatt, MD, Izidore S Lossos, MD

Blood (2013) 122 (21): 377.

https://doi.org/10.1182/blood.V122.21.377.377

Published: 2013

Journal Articles

Germinal Center Kinase Regulates The Proliferation and Survival Of Diffuse Large B-Cell Lymphoma

Blood (2013) 122 (21): 643.

https://doi.org/10.1182/blood.V122.21.643.643

Published: 2013

Journal Articles

Interaction of HGAL with Grb2 Enhances RhoA and B-Cell Receptor Signaling

Xiaoyu Jiang, PhD, Xiaoqing Lu, M.D, Izidore S Lossos, MD

Blood (2012) 120 (21): 681.

https://doi.org/10.1182/blood.V120.21.681.681

Published: 2012

Journal Articles

MiR-181a Is a Master Regulator of the Nuclear Factor-κB Signaling Pathway in Diffuse Large B Cell Lymphoma

Goldi A. Kozloski, PhD, Xiaoyu Jiang, PhD, Karen L. Bunting, PhD, Ari M. Melnick, MD, Izidore S Lossos, MD

Blood (2012) 120 (21): 417.

https://doi.org/10.1182/blood.V120.21.417.417

Published: 2012

Journal Articles

Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma

Elena Cubedo, Andrew J. Gentles, Chuanxin Huang, Yasodha Natkunam, Shruti Bhatt, Xiaoqing Lu, Xiaoyu Jiang, Isabel Romero-Camarero, Aharon Freud, Shuchun Zhao, Carlos E. Bacchi, Jose A. Martínez-Climent, Isidro Sánchez-García, Ari Melnick, Izidore S. Lossos

Blood (2012) 119 (23): 5478–5491.

https://doi.org/10.1182/blood-2012-01-403154

Published: 2012

Includes: Supplemental data

NARROW

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study

Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice

Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma

miR-181a negatively regulates NF-κB signaling and affects activated B-cell–like diffuse large B-cell lymphoma pathogenesis

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo

FBXO10 Targets HGAL for Degradation

Grb2 Directly Interacts with HGAL and Ameliorates Its Effects on B-Cell Receptor Signaling

Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma

HGAL localization to cell membrane regulates B-cell receptor signaling

Mirna-181a expression Lead to Longer Animal Survival and Slower Tumor-Growth Rate in Diffuse Large B-Cell Lymphoma Xenograft Models

Integrative Genomics Reveals a Role for GNA13 in Lymphomagenesis within the Germinal Center Niche

Targeting B-Cell Malignancies With Anti-CD20-Interleukin-21 Fusokine

Germinal Center Kinase Regulates The Proliferation and Survival Of Diffuse Large B-Cell Lymphoma

Interaction of HGAL with Grb2 Enhances RhoA and B-Cell Receptor Signaling

MiR-181a Is a Master Regulator of the Nuclear Factor-κB Signaling Pathway in Diffuse Large B Cell Lymphoma

Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only